The health department argues that a co-payment reduction is the most effective way to address medicine affordability, but acknowledges the complexity of adherence and admits that non-concessional Australian patients will continue to face significant cost barriers compared to those in other countries.
Government admits general safety net is 'significantly higher' than comparable countries
July 31, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Trump administration takes another step in 'Most Favored Nation' push
August 1, 2025 - - Latest News -
Arrotex expands haematology-oncology portfolio through Antengene partnership
August 1, 2025 - - Latest News -
Study reveals growing benefit of Lilly therapy for early symptomatic Alzheimer’s disease
August 1, 2025 - - Latest News -
Novartis backs the launch of a new cardiovascular disease program
August 1, 2025 - - Latest News -
New pharmacy-focused partnership marks the launch of two first-to-market biosimilars
August 1, 2025 - - Latest News -
AusBiotech and Medicines Australia celebrate Catalyst outcomes and further strengthen industry collaboration
August 1, 2025 - - Latest News -
AbbVie therapy now available on the PBS for treatment of advanced Parkinson’s
August 1, 2025 - - Latest News